7.1 million patients worldwide are remotely monitored, 2
million from ResMed alone
SAN DIEGO, Feb. 13, 2017 /CNW/ -- ResMed's global lead
in remote patient monitoring kept growing in 2016, even as the
industry itself continued to expand, according to the annual
mHealth & Home Monitoring report released by independent
technology analyst firm Berg Insight.
Roughly 7.1 million patients were remotely monitored by the end
of 2016 on sleep, ventilator, diabetic, cardiovascular or other
therapy, according to the mHealth report. That's up 45 percent from
4.9 million patients at the end of 2015.
"The number of remotely monitored sleep therapy patients grew by
70 percent in 2016," the report states, "with market growth mainly
driven by the vendor ResMed that has made connected healthcare a
cornerstone of its strategy."
"ResMed has been delivering on its promise to help
streamline sleep therapy for patients and providers with
digital solutions for over a decade, and we will
continue to focus on connected care as we execute our
growth strategy," said ResMed CEO Mick
Farrell. "As the leading tech-driven medical device company,
we have more than one billion nights of sleep data, and
our digital health apps are clinically-proven to improve patient
adherence. We strive every day to improve quality of life for
patients, slow the progression of chronic disease and
reduce the overall costs of our global healthcare system."
About ResMed
ResMed (NYSE:RMD) changes lives with award-winning medical
devices and cutting-edge cloud-based software applications that
better diagnose, treat and manage sleep apnea, chronic obstructive
pulmonary disease (COPD) and other chronic diseases. ResMed is a
global leader in connected care, with more than 2 million patients
remotely monitored every day. Our 5,000-strong team is
committed to creating the world's best tech-driven medical device
company – improving quality of life, reducing the impact of chronic
disease, and saving healthcare costs in more than 100
countries.
ResMed.com | Facebook | Twitter | LinkedIn
For
media:
|
For
investors:
|
Alison
Graves
|
Agnes Lee
|
858-836-6789
|
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/resmed-named-global-leader-in-remote-patient-monitoring-300405754.html
SOURCE ResMed Inc.